HSBC Holdings
BIOR

HSBC Holdings’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

HSBC Holdings’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-41
Closed -$91K – 3183
2020
Q3 		$91K Buy
+41
New +$92.7K ﹤0.01% 2635

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSBC Holdings's BIOR Position: Q4 2020 in Review

HSBC Holdings sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2020, closing a stake of 41 shares — an estimated $91K sold.

HSBC Holdings first reported a position in BIOR in Q3 2020 and held it in 1 quarter. The position peaked at $91K in Q3 2020. 48 funds tracked by Wall St. Rank hold BIOR as of Q4 2020.

  • HSBC Holdings reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • HSBC Holdings sold 41 Biora Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $91K.
  • HSBC Holdings first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • HSBC Holdings's Biora Therapeutics, Inc. Common Stock position peaked at $91K in Q3 2020.
  • 48 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2020.

Based on HSBC Holdings's 13F filing for Q4 2020, filed 12 Feb 2021.